DALLAS & EDINBURGH, Scotland--(BUSINESS WIRE)--Celanese Corporation (NYSE: CE), a global technology and specialty materials company, invites attendees of the Drug Delivery to the Lungs Forum (DDL 26) to visit with its medical technology polymer experts December 9-11, 2015 in the Edinburgh International Conference Center, Scotland, UK, to learn about the company’s broad portfolio of high quality, medical grade engineered polymers.
“Celanese has for years been a leading, global engineered materials supplier to the medical device market,” said Wendy Johnson, medical marketing manager for Celanese. “We continue to expand our engineered polymers portfolio to deliver innovative material solutions that are improving the experience of the end-user and meeting the growing demands of medical suppliers worldwide.”
Celanese will be showcasing its Hostaform® MT® SlideX™ POM product, a thermoplastic polymer that is an excellent low-friction solution for the following applications:
- pressurized Metered Dose Inhalers (pMDIs)
- dry powder inhalers
- spray pumps
“Studies show that patients are more likely to comply with medication regimens when using medical devices that are comfortable and easy to use,” said Johnson. “Celanese provides quality medical polymers to help our customers develop devices with patient needs in mind and improve the user experience.”
Celanese materials experts will be meeting with attendees at DDL 26 in booth 96 to discuss their latest project challenges and medical device innovations. For more information on Celanese Hostaform® MT® SlideX™ POM, visit http://celanese.com/webinars.
Celanese Corporation is a global technology leader in the production of differentiated chemistry solutions and specialty materials used in most major industries and consumer applications. With sales almost equally divided between North America, Europe and Asia, the company uses the full breadth of its global chemistry, technology and business expertise to create value for customers and the corporation. Celanese partners with customers to solve their most critical needs while making a positive impact on its communities and the world. Based in Dallas, Texas, Celanese employs approximately 7,500 employees worldwide and had 2014 net sales of $6.8 billion. For more information about Celanese Corporation and its product offerings, visit www.celanese.com or our blog at www.celaneseblog.com.
All registered trademarks are owned by Celanese International Corporation or its affiliates.
This release may contain “forward-looking statements,” which include information concerning the company’s plans, objectives, goals, strategies, future revenues or performance, capital expenditures, financing needs and other information that is not historical information. When used in this release, the words “outlook,” “forecast,” “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the company or any of its customers will realize these benefits or that these expectations will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained in this release. Numerous factors, many of which are beyond the company’s control, could cause actual results to differ materially from those expressed as forward-looking statements. Other risk factors include those that are discussed in the company’s filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.